MMedication Read More Some patients experience mental health backlash from GLP-1 medicationsFebruary 3, 2026 The use of GLP-1 weight loss medications is skyrocketing in the United States, more than doubling since 2024.…
MMedication Read More Quitting Ozempic Is a Risky Proposition – NewserJanuary 31, 2026 Quitting Ozempic Is a Risky Proposition NewserExclusive | The rise of ‘agonorexia’: GLP-1s feeding dangerous food and body image…
NNutrition Read More New year will see protein innovation, fiber-maxxing trend & healthspan focus boomJanuary 20, 2026 Nutrition companies are gearing up for 2026 with new insights on evolving consumer needs shaped by emerging health…
NNutrition Read More Industry insights on reshaping nutrition for the GLP-1 consumerJanuary 16, 2026 Amid growing access to GLP-1s, particularly in the US, the food and nutrition industries are exploring how to…
MMedication Read More Health Canada approves 1st GLP-1 daily pill. Here’s who can take it – NationalJanuary 13, 2026 Health Canada has approved a GLP-1 pill for the first time. The once-a-day semaglutide pill is approved for…
HHealth Read More Pharmacist says ingredients work ‘like weight loss jabs’January 10, 2026 With 28% of UK adults now classified as obese – and a further 36% overweight – it’s little…
NNutrition Read More WHO guidance on GLP-1, nutrition innovations for longevity and the global omega-3 gapJanuary 9, 2026 December’s highlights include FrieslandCampina Ingredients’ planned expansion of its whey protein business and North American footprint, research findings…
MMedication Read More GLP-1 weight loss drugs like Ozempic can cause muscle loss without proper diet and exerciseJanuary 7, 2026 SOUTHFIELD, Mich. – As fitness resolutions surge with the new year, many are turning to GLP-1 medications like…
MMedication Read More GLP-1 drugs like Ozempic and Wegovy are changing the foods Americans buyDecember 30, 2025 The impact of popular U.S. weight-loss drugs like Ozempic and Wegovy (GLP-1 receptor agonists), upon their initial introduction…
NNutrition Read More AI tech, personalized solutions, and nutrition security in the GLP-1 eraDecember 26, 2025 As we prepare to turn the page on the year, Nutrition Insight revisits some of the most significant…
MMedication Read More Major Medicare Changes Announced For Certain DrugsDecember 24, 2025 Major changes that will increase access to GLP-1 weight loss drugs—widely regarded as critical for weight management and…
MMedication Read More FDA Approves Pill Version of WegovyDecember 23, 2025 The US Food and Drug Administration today approved a pill version of the blockbuster anti-obesity drug Wegovy. Made…